Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences has excelled in the last Research Excellence Framework (REF) results.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences has excelled in the last Research Excellence Framework (REF) results.

The REF assesses the quality and impact of research submitted by universities across all disciplines, with the latest results showing top-ranking for Oxford’s clinical medicine.

NDORMS submitted to the REF’s Unit of Assessment 1 - Clinical Medicine - alongside other academic departments, and contributed significantly to the excellent results of UoA1 at Oxford; the sub-panel welcomed the strong return in orthopaedic sciences, as well as the outstanding reach and significance of the impacts from research in musculoskeletal and ageing.

Professor Andrew Carr, Head of NDORMS, said: "NDORMS has made a significant contribution to the nationally top ranked submission from the University of Oxford. It is particularly gratifying to have been specifically mentioned by the assessment panel for both the quality of our publications and the impact of our research. This is a testament to the world class multidisciplinary researchers working in the department."

The results for UoA1 show Clinical Medicine at Oxford ranked top on overall REF research profile (GPA rank) using all quality scores. Overall, we were also top ranked with maximum 4* score, where 53% of overall submissions were judged to be world-leading for originality, significance and rigour, and 92% of our overall quality profile was rated as ‘world leading’ or ‘internationally excellent’. On addition, 82% of our research impacts were scored 4* - outstanding in terms of reach and significance - and 18% scored 3*.

You can see an example of how research at NDORMS significantly impacts people’s lives in this short video on fighting arthritis.

Read more on the University’s page and see the University's REF 2014 results table.

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.